via NEWMEDIAWIRE -- Attis Industries, Inc.(NASDAQ: ATIS) (the
“Company” or “Attis”), a diversified innovation and technology
holding company, today announced the appointments of Ms. Maggie
Arvedlund and Dr. David Rivers to Attis’ Board of Directors (the
“Board”) via a unanimous vote at its recent board
meeting. These appointments, which are effective
immediately, aim to enhance the Board’s financial and capital
markets experience.
Jeff Cosman, Chief Executive Officer, said, “We
are thrilled to announce the appointments of Ms. Arvedlund and Dr.
Rivers to our Board of Directors. Ms. Arvedlund’s deep
and diversified background in both debt and equity securities
brings instant capital markets experience that Attis will harness
as we aggressively move forward. Likewise, Dr. Rivers’
more than four decades of public service experience will be
critical in shaping Attis’ policy initiatives that will drive
various business segment growth well into the future.”
Cosman added, “We look forward to working with Ms.
Arvedlund and Dr. Rivers as we continue to build Attis into a
global leader through technology and innovation and create
shareholder value.”
Biographical information on the two newly elected
board members is as follows:
Maggie Arvedlund
Ms. Arvedlund is CEO and Managing Partner of
Turning Rock Partners (“Turning Rock”), a New York-based principal
investment firm. Turning Rock seeks to make long-term investments
in debt and equity securities of North American small and
mid-capitalization businesses. The firm emphasizes return of
principal and inherent cash flow throughout portfolio construction
and employs time-tested credit and equity research, while
performing deep dive analytics on each potential investment through
a combination of financial, operational, and qualitative
analysis.
Prior to founding Turning Rock, Ms. Arvedlund was
a Managing Director at Fortress Investment Group
(“Fortress”). While at Fortress, Ms. Arvedlund was
responsible for private equity and debt investments for the
Fortress Partners Fund, a multi-strategy vehicle which invested
across asset classes and capital structures. Ms.
Arvedlund served on the Investment Committee of Fortress from
2010-2015 and allocated capital across the alternative landscape
including hedged equity, private equity, real estate, distressed
and other hard assets. Prior to joining Fortress, Ms.
Arvedlund worked at Hall Capital Partners where she held roles in
the portfolio management and research divisions. She has
also held a number of senior operating roles in several privately
held businesses.
Ms. Arvedlund received a BS with Honors from
Vanderbilt University in Economics and an MBA in Finance from NYU's
Stern School of Business. Ms. Arvedlund serves on
several non-profit boards including Summer Search New York City and
is a founding member of the NYU Stern Private Equity Advisory
Board.
Dr. David E. Rivers, DHL
Dr. Rivers serves as Professor and Director of the
Public Information and Community Outreach at the Medical University
of South Carolina. He has served the University of South
Carolina in a number of capacities since January 1995.
During the past forty years, he has held
senior-level positions in the City of Atlanta government, the
Atlanta Regional Commission, Georgia State University, the U.S.
Department of Health and Human Services, the U.S. Department of
Energy and the District of Columbia Government.
Dr. Rivers received his Bachelor of Science degree
in Urban Affairs from Georgia State University and his Master of
Arts degree in Political Science/Public Administration from Georgia
State University, where he has completed course work for the Ph.D.
in Political Science. He is also a graduate of the National
Urban Fellows Program in Public Administration from Yale
University. He is a graduate of the Riley Institute
Diversity Leadership Program at Furman University and received an
Honorary Doctorate of Humane Letters from Allen
University. In addition, Dr. Rivers served three years
in the U.S. Army.
Dr. Rivers serves as Board Chairman of the
National Urban Fellows in New York, NY. He also serves as
Chairman of the James E. Clyburn Research and Scholarship
Foundation. He is also President of the Jonathan Green
Foundation. Dr. Rivers is Vice Chairman of the Sea Island
Comprehensive Health Care Corporation.
He is a member of the National Forum for Black
Public Administrators, American Water Works Association, Water
Environment Federation, and the 100 Black Men of Charleston,
SC. Dr. Rivers is a Board Member of the South Carolina
Aquarium in Charleston, SC; My Brothers Keeper, Charleston, SC;
National Council of La Raza ~ California State University Center
for Latino Community Health in Monterey Bay, California; Allen
University Board of Trustees in Columbia, SC; the Congressional
Black Caucus Institute’s 21stCentury Council Executive Committee;
Advisory Board Member of Charleston First Reliance Bank; and the
Trident Urban League. He has also served as a Board Member of
the Community Foundation and the Charleston Regional Development
Alliance. In addition, he was elected as a Commissioner of
Public Works for the City of Charleston in 2003 and was re-elected
in September of 2009 and 2015 unopposed, where he serves as Vice
Chairman.
Attis Industries, Inc.
Attis Industries Inc. (NASDAQ: ATIS) is a
diversified innovation and technology holding company focused on
developing and building businesses that play important roles in the
new economy. We strive to encourage our employees to be
entrepreneurs focused on innovation and technology. We
will remain dynamic, persistent and motivated to our mission of
winning. The growth of our company will rely on our
integrity and our vision for the future. Today, each of
Attis business sectors provide high growth opportunities that
collectively account for more than a third of our nations
GDP. For more information,
visit: www.attisind.com
Forward-Looking Statements
Any statements contained in this press release
that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. You can identify
forward-looking statements by words such as “anticipate,”
“believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,”
“should,” “would” or similar words. You should consider these
statements carefully because they discuss our plans, targets,
strategies, prospects and expectations concerning our business,
operating results, financial condition and other similar matters.
These statements are subject to certain risks, uncertainties, and
assumptions, including, but not limited to, risks and uncertainties
relating to the Company's ability to develop, market and sell
products based on its technology; the expected benefits and
efficacy of the Company's products and technology; the availability
of substantial additional funding for the Company to continue its
operations and to conduct research and development, clinical
studies and future product commercialization; and, the Company's
business, research, product development, regulatory approval,
marketing and distribution plans and strategies; the ability of the
Company to continue to meet the listing requirements of NASDAQ; the
ability of the Company to execute on a business plan that permits
the technologies and innovations businesses to provide sufficient
growth, revenue, liquidity and cash flows for sustaining the
Company’s go-forward business, and the risks identified and
discussed under the caption “Risk Factors” in the Attis Annual
Report on Form 10-K for the fiscal year ended December 31, 2017,
filed with the Securities and Exchange Commission (the “SEC”) on
April 16, 2018 and the other documents Attis files with the SEC
from time to time. There will be events in the future, however,
that Attis is not able to predict accurately or control. Attis’s
actual results may differ materially from the expectations that
Attis describes in its forward-looking statements. Factors or
events that could cause Attis’s actual results to materially differ
may emerge from time to time, and it is not possible for Attis to
accurately predict all of them. Any forward-looking statement made
by Attis in this press release speaks only as of the date on which
Attis makes it. Attis undertakes no obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
ir@attisind.com
Kevin M. McGrath
TraDigital IR
(212) 389-9782 x104
kevin@tradigitalir.com
Grafico Azioni Attis Industries (NASDAQ:ATIS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Attis Industries (NASDAQ:ATIS)
Storico
Da Giu 2023 a Giu 2024